Regulus, UCSD Form Alliance

Xconomy San Diego — 

San Diego-based Regulus Therapeutics, the developer of microRNA therapies, said today it has formed a research collaboration with UC San Diego. The partners will seek to develop microRNA therapies that work to block new blood vessel formation (anti-angiogenesis), as a way to treat various diesases, Regulus said in a statement. Financial terms of the deal aren’t being disclosed, although the work is being supported by a UC Discovery Grant, Regulus said.